DAVENPORT & Co LLC Has $1.17 Million Stake in The Clorox Company $CLX

DAVENPORT & Co LLC reduced its holdings in The Clorox Company (NYSE:CLX) by 5.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 9,754 shares of the company’s stock after selling 553 shares during the period. DAVENPORT & Co LLC’s holdings in Clorox were worth $1,171,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CLX. Park Avenue Securities LLC bought a new position in shares of Clorox in the 1st quarter valued at about $258,000. Farther Finance Advisors LLC grew its holdings in shares of Clorox by 25.4% in the 1st quarter. Farther Finance Advisors LLC now owns 5,872 shares of the company’s stock valued at $869,000 after acquiring an additional 1,190 shares in the last quarter. Wealthcare Advisory Partners LLC grew its holdings in shares of Clorox by 47.8% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 2,350 shares of the company’s stock valued at $346,000 after acquiring an additional 760 shares in the last quarter. Integrated Advisors Network LLC grew its holdings in shares of Clorox by 98.1% in the 1st quarter. Integrated Advisors Network LLC now owns 4,338 shares of the company’s stock valued at $639,000 after acquiring an additional 2,148 shares in the last quarter. Finally, CX Institutional grew its holdings in shares of Clorox by 4.8% in the 1st quarter. CX Institutional now owns 2,964 shares of the company’s stock valued at $436,000 after acquiring an additional 136 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Up 0.1%

Clorox stock opened at $120.14 on Friday. The stock has a market cap of $14.63 billion, a P/E ratio of 18.43, a P/E/G ratio of 0.98 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The company’s 50-day moving average price is $122.21 and its two-hundred day moving average price is $128.79.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s payout ratio is currently 76.07%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CLX shares. TD Cowen decreased their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. The Goldman Sachs Group reduced their price target on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. JPMorgan Chase & Co. reduced their price target on Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a report on Friday. Morgan Stanley reduced their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Clorox in a report on Saturday, September 27th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $131.92.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.57% of the stock is owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.